Mamas on Bedrest: Are We on the Brink of a Cure for Pre-Eclampsia?May 2nd, 2014
May is Pre-Eclampsia Awareness Month. As our way of honoring this occasion, I present to you an interview that I did with Dr. Karine Kleinhaus. Dr. Kleinhaus is the Divisional Vice President North America for and Israeli based biotechnology company called Pluristem Therapeutics, Inc. Pluristem is a leading developer of placental based cell therapies. They are currently developing a treatment that, if effective, will treat pre-eclampsia in pregnant women and very likely remove the need for women to be placed on bed rest for pre-eclampsia.
As you can image, when I first learned of this technology, I was floored. Then I got excited. Pre-eclampsia is one of the leading reasons that Mamas are prescribed bed rest during their pregnancies. It can have serious health consequences for mamas and their babies, including kidney and liver damage in mamas, prematurity and the associated developmental issues in infants and even death. Pre-Eclampsia is thought to be the result of inflammation in the uterus and with the placenta that leads to the elevated blood pressure, the protein in the urine, liver assault and, if not adequately treated progresses to HELLP Syndrome (High blood pressure, Elevated Liver Enzymes and Low Platelets).
In February of this year, The American Heart Association and the American Stroke Association announced that new research data shows that women who have pre-eclampsia during their pregnancies are at increased risk of heart disease and stroke in later life. So as you can imagine, if the therapy being developed by Pluristem is successful, many women stand to be saved a lot of discomfort from a potentially life threatening illness during their pregnancies, will avoid bed rest and its complications and avoid the risk to their cardiovascular health later in life. This is win-win-win!!
Dr. Kleinhaus was kind enough to spend quite a lot of time with me explaining the treatment and its potential in the treatment of Pre-Eclampsia. Listen to this interview carefully. It’s really interesting and chocked full of very useful information. Once you finish, share your comments in the comments section below.